Any burn, injury, or trauma such as surgeries can cause a scar on the skin. Scarring is a natural healing process, which occurs after an injury. Its appearance and treatment depend on multiple factors such as the depth and size of the wound or the cut. It also depend upon the location of the wound, age, sex, and genes. There are various types of scars such as keloid scars, contracture scars, acne scars, and hypertrophic scars. Keloid scars are formed due to an over-aggressive healing process. They usually extend beyond their original location of the injury. Treatment of keloid scars include surgery, steroid injections, silicone sheets, and others. Hypertrophic scars are raised red scars and treatment of these scars include injection of steroids or silicone sheets.

Market Dynamics

Market players are engaged in inorganic growth activities such as acquisitions, and this is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. For instance, in April 2019, Merz, a company involved in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, an innovative U.S. consumer healthcare company, entered into an agreement to acquire the asset purchase agreement, according to which HRA Pharma will acquire the U.S. rights to the Mederma brand of Merz, which includes products across the scar care, stretch marks, and skincare categories.

Moreover, in October 2019, 3M, a multinational conglomerate corporation operating in the fields of industry, worker safety, health care, and consumer goods, completed the acquisition of Acelity, Inc., a medical device company, to expand its surgical applications business, which include advanced wound care and specialty surgical applications marketed under the KCI brand (PROMOGRAN) in the developed economies such as the U.S.

Key features of the study:

• This report provides an in-depth analysis of the S. post-surgical scar treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the U.S. post-surgical scar treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The U.S. post-surgical scar treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the U.S. post-surgical scar treatment market

Detailed Segmentation:

• U.S. Post-Surgical Scar Treatment Market, By Product Type:
  • Silicone sheets & Patches
  • Surgical tapes
  • Strips
  • Gels & Creams
  • Others
• U.S. Post-Surgical Scar Treatment Market, By Channel:
  • OTC
  • Rx
• U.S. Post-Surgical Scar Treatment Market, By Scar Type:
  • Atrophic Scars
  • Hypertrophic Scars
  • Keloid Scars
  • Contracture Scars
• U.S. Post-Surgical Scar Treatment Market, By Surgery Type:
  • Caesarean Section
  • Joint Replacement
  • Appendectomy
  • Heart Surgery
  • Breast surgery
  • Others
• U.S. Post-Surgical Scar Treatment Market, By End User:
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings
  • Hospitals
• Company Profiles
  • Smith & Nephew Plc. *
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • 3M
  • Cardinal Health
  • Merz Pharma
  • Biodermis
  • Scar Heal, Inc.
  • Mölnlycke Health Care AB
  • Implantech
  • Covalon Technologies Ltd.
  • Bio Med Sciences
  • Polymer Science, Inc.
  • Neodyne Biosciences, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.